Persica’s approach has been to bring together a highly experienced and qualified team that has extensive knowledge of the drug development and clinical trial processes required to bring a new product to market.
Persica Pharmaceuticals aims to bring forward a new therapy to treat patients suffering from Chronic Lower Back Pain (CLBP), a debilitating condition that significantly affects quality of life for which existing treatments are often ineffective.
Our Therapeutic Focus
Building on ground-breaking research. which has demonstrated that Chronic Lower Back Pain (CLBP) can be caused by bacterial infection and treated with antibiotics, Persica Pharmaceuticals aims to bring forward a new treatment to alleviate this serious and debilitating condition.